# SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1

> **NCT00313937** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 91 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin glargine

## Key facts

- **NCT ID:** NCT00313937
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2004-06
- **Final completion:** —
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2009-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00313937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00313937, "SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00313937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*